Damora Therapeutics
DMRA
#5597
Rank
NZ$2.51 B
Marketcap
NZ$40.80
Share price
3.89%
Change (1 day)
286.25%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -NZ$0.46 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.38 Billion a decrease over its 2024 earnings that were of -NZ$38.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.46 Billion21.84%
2025 -NZ$0.38 Billion880.41%
2024 -NZ$38.06 Million-44.2%
2023 -NZ$68.21 Million-37.77%
2022 -NZ$0.11 Billion19.08%
2021 -NZ$92.05 Million48.55%
2020 -NZ$61.96 Million